Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $77.2950 (1.14%) ($77.2950 - $77.2950) on Wed. Apr. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.48% (three month average) | RSI | 68 | Latest Price | $77.2950(1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(49%) XBI(49%) IWM(48%) IWC(46%) IWO(46%) | Factors Impacting LGND price | LGND will decline at least -1.24% in a week (0% probabilities). VXX(-19%) VIXM(-14%) UUP(-13%) SMH(-13%) SHY(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.24% (StdDev 2.48%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $76.85(0.58%) | 10 Day Moving Average | $76.44(1.12%) | 20 Day Moving Average | $74.48(3.78%) | To recent high | -0.6% | To recent low | 14.8% | Market Cap | $1.242b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |